Christian Eriksen collapsed about 65 minutes into Denmark's friendly against Ukraine in Odense on Sunday 7 June. His implanted cardioverter-defibrillator (ICD), a device that detects a dangerous heart rhythm and delivers a shock to correct it, fired for the second time since his 2021 cardiac arrest at Euro 2020. The match was abandoned with Denmark leading 2-1. Denmark missed out on the 2026 finals, so the collapse fell outside the tournament itself.
Denmark's team doctor Mogens Kreutzfeldt Boesen confirmed the device worked correctly: "He was briefly gone, but very quickly regained consciousness; pacemaker working as it should"1. Eriksen left hospital the same evening, Danish medical staff said. The ICD was fitted following his on-pitch arrest at the European Championship, and Eriksen returned to professional football wearing it, a decision watched closely across the sport.
The collapse landed in a pre-tournament window already defined by veteran careers running long: the 2026 field is the oldest on record, with goalkeepers and forwards in their late thirties and one player at 43. Eriksen, 34, belongs to that cohort of players still competing at the top with bodies that have been through more than most. A second device activation in a competitive setting, even a friendly, renews the question that has trailed his career since 2021: how a player and his clinicians weigh continued elite competition against a heart condition the ICD exists to catch.
